As of 2024-12-14, the Relative Valuation of Qiagen NV (QGEN) is 33.38 USD. This relative valuation is based on P/E multiples. With the latest stock price at 45.40 USD, the upside of Qiagen NV based on Relative Valuation is -26.5%.
The range of the Relative Valuation is 13.05 - 55.46 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.2x - 34.8x | 33.4x |
| Forward P/E multiples | 28.3x - 32.3x | 30.8x |
| Fair Price | 13.05 - 55.46 | 33.38 |
| Upside | -71.2% - 22.2% | -26.5% |
| Date | P/E |
| 2024-12-13 | 108.58 |
| 2024-12-12 | 109.92 |
| 2024-12-11 | 110.40 |
| 2024-12-10 | 110.18 |
| 2024-12-09 | 106.00 |
| 2024-12-06 | 103.84 |
| 2024-12-05 | 103.87 |
| 2024-12-04 | 104.68 |
| 2024-12-03 | 103.53 |
| 2024-12-02 | 104.39 |
| 2024-11-29 | 103.87 |
| 2024-11-27 | 104.63 |
| 2024-11-26 | 103.41 |
| 2024-11-25 | 103.44 |
| 2024-11-22 | 102.31 |
| 2024-11-21 | 101.24 |
| 2024-11-20 | 100.66 |
| 2024-11-19 | 97.58 |
| 2024-11-18 | 98.03 |
| 2024-11-15 | 98.70 |
| 2024-11-14 | 100.66 |
| 2024-11-13 | 101.95 |
| 2024-11-12 | 103.39 |
| 2024-11-11 | 105.35 |
| 2024-11-08 | 104.66 |
| 2024-11-07 | 105.59 |
| 2024-11-06 | 104.92 |
| 2024-11-05 | 105.11 |
| 2024-11-04 | 104.39 |
| 2024-11-01 | 103.03 |
| 2024-10-31 | 100.69 |
| 2024-10-30 | 101.02 |
| 2024-10-29 | 100.04 |
| 2024-10-28 | 99.97 |
| 2024-10-25 | 99.37 |
| 2024-10-24 | 99.49 |
| 2024-10-23 | 100.73 |
| 2024-10-22 | 100.95 |
| 2024-10-21 | 100.73 |
| 2024-10-18 | 102.84 |
| 2024-10-17 | 102.10 |
| 2024-10-16 | 103.34 |
| 2024-10-15 | 104.94 |
| 2024-10-14 | 105.45 |
| 2024-10-11 | 105.04 |
| 2024-10-10 | 103.51 |
| 2024-10-09 | 106.31 |
| 2024-10-08 | 104.18 |
| 2024-10-07 | 103.60 |
| 2024-10-04 | 104.20 |